Skip to content
ProPublica Donate
ProPublica Donate

Baylor Research Institute

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Medical Research / Medical Specialty Research (NTEE)

Donations to this organization are tax deductible.

Details

According to its June 2023 tax filing, this nonprofit:

Reported conflict of interest transactions
Organizations must report loans, grants or business transactions with interested parties, which may include key employees and officers, their family members and any businesses in which they hold a controlling interest. These transactions must be reported on Schedule L.

Summary charts: organization finances over time

Revenue
$73.3M (2023)

Expenses
$76.7M (2023)

Total Assets
$158M (2023)

Total Liabilities
$11.6M (2023)

Source: Form 990 tax filings from 2011 to 2023

Tax Filings by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Fiscal Year Ending June
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$73,307,762
Expenses
$76,665,102
Net Income
-$3,357,340
Net Assets
$145,996,311
Notable Sources of Revenue Percent of Total Revenue
Contributions $36,075,918
49.2%
Program Services $25,223,172
34.4%
Investment Income $237,575
0.3%
Bond Proceeds $0
Royalties $10,853,602
14.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $917,495
1.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,424,913
1.9%
Professional Fundraising Fees $0
Other Salaries and Wages $37,239,378
48.6%
Assets/Debt
Total Assets $157,601,006
Total Liabilities $11,604,695
Net Assets $145,996,311
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Javed Butler Md (Trustee/President/Ceo) $631,586 $0 $64,063
Gerard Zurawski (Dir Institute Immun Rsrch) $319,620 $0 $15,779
Alan Stevens (Research Center Dir) $293,674 $0 $26,640
Jennifer Thomas (Vp Research Operations) $289,273 $0 $41,468
Elizabeth Cothran (Vp Chief Regulatory Officer) $276,951 $0 $44,778
Simon Driver (Research Center Dir) $275,746 $0 $34,435
Teodoro Bottiglieri (Dir Institute Immun Rsrch) $255,349 $0 $21,688
Suzy Gulliver (Research Center Dir) $253,128 $0 $33,479
Alejandro Arroliga Md (Trustee) $0 $1,677,582 $438,520
Michael J Mack Md (Trustee/Chair) $0 $705,092 $19,486
Steven Newton (Trustee) $0 $1,595,379 $401,848
Mitch Dean (Secretary) $0 $371,817 $53,564
Amy Martin (Vp Cfo) $0 $373,384 $72,515

Document Links

Fiscal Year Ending June
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$70,312,625
Expenses
$68,170,124
Net Income
$2,142,501
Net Assets
$152,303,796
Notable Sources of Revenue Percent of Total Revenue
Contributions $39,757,092
56.5%
Program Services $20,819,455
29.6%
Investment Income $74,891
0.1%
Bond Proceeds $0
Royalties $8,272,921
11.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $21,551
0.0%
Net Inventory Sales $0
Other Revenue $1,366,715
1.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $936,675
1.4%
Professional Fundraising Fees $0
Other Salaries and Wages $31,928,498
46.8%
Assets/Debt
Total Assets $163,970,510
Total Liabilities $11,666,714
Net Assets $152,303,796
Compensation
Key Employees and Officers Compensation Related Other
Jennifer Thomas (Vp Research Operations) $324,196 $0 $53,033
Gerard Zurawski (Dir Institute Immun Rsrch) $316,752 $0 $17,283
Alan Stevens (Research Center Dir) $290,804 $0 $25,269
Teodoro Bottiglieri (Dir Institute Immun Rsrch) $286,018 $0 $23,287
Elizabeth Cothran (Vp Chief Regulatory Officer) $274,508 $0 $43,231
Simon Driver (Research Center Dir) $247,955 $0 $33,380
Elisa Priest (Director Clinical Informatics) $245,777 $0 $35,274
Steven Newton (Trustee) $0 $1,524,850 $361,208
Alejandro Arroliga Md (Trustee) $0 $1,473,245 $410,789
Michael J Mack Md (Trustee/Chair/Pres/Ceo) $0 $605,112 $18,716
Amy Martin (Vp Cfo) $0 $365,089 $71,004
Mitch Dean (Secretary) $0 $337,530 $50,219
Michael Ramsay Md (Former Officer) $0 $126,950 $8,113
Javed Butler Md (Trustee/Chair/Pres/Ceo (Eff 3/25/22)) $0 $0 $0

Document Links

Fiscal Year Ending June
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$77,117,798
Expenses
$65,145,979
Net Income
$11,971,819
Net Assets
$156,856,910
Notable Sources of Revenue Percent of Total Revenue
Contributions $36,056,264
46.8%
Program Services $32,559,788
42.2%
Investment Income $79,001
0.1%
Bond Proceeds $0
Royalties $7,649,483
9.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $116,550
0.2%
Net Inventory Sales $0
Other Revenue $656,712
0.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $895,697
1.4%
Professional Fundraising Fees $0
Other Salaries and Wages $29,444,354
45.2%
Assets/Debt
Total Assets $167,191,620
Total Liabilities $10,334,710
Net Assets $156,856,910
Compensation
Key Employees and Officers Compensation Related Other
Jaime Walkowiak (Sect/Svp Chief Rsch) $437,751 $0 $70,072
Gerard Zurawski (Dir Institute Immun Rsrch) $316,265 $0 $16,930
Alan Stevens (Research Center Dir) $288,314 $0 $24,679
Elizabeth Cothran (Vp Chief Regulatory Officer) $271,138 $0 $49,484
Jennifer Fox (Secretary/Vp Rsch Ops) $261,326 $0 $30,978
Simon Driver (Research Center Dir) $257,827 $0 $33,024
Jennifer Thomas (Vp Research Operations) $255,572 $0 $46,557
Suzy Gulliver (Investigator) $239,416 $0 $32,560
Steven Newton (Trustee) $0 $1,621,572 $321,037
Alejandro Arroliga Md (Trustee) $0 $1,269,131 $290,153
Michael J Mack Md (Trustee/Chair/President/Ceo) $0 $760,055 $18,212
Michael Ramsay Md (President/Ceo) $0 $488,167 $36,693
Amy Martin (Vp Cfo) $0 $350,947 $57,939

Document Links

Fiscal Year Ending June
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$71,333,023
Expenses
$66,124,848
Net Income
$5,208,175
Net Assets
$130,252,019
Notable Sources of Revenue Percent of Total Revenue
Contributions $35,615,550
49.9%
Program Services $29,000,317
40.7%
Investment Income $139,997
0.2%
Bond Proceeds $0
Royalties $6,361,014
8.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$48,652
Net Inventory Sales $0
Other Revenue $264,797
0.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,010,096
1.5%
Professional Fundraising Fees $0
Other Salaries and Wages $29,142,303
44.1%
Assets/Debt
Total Assets $139,937,615
Total Liabilities $9,685,596
Net Assets $130,252,019
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Jaime Walkowiak (Secretary/Svp Chief Research Exec) $487,836 $0 $69,192
Gerard Zurawski (Director Inst. Immunology) $316,745 $0 $16,686
Alan Stevens (Dir Comm & Applied Health) $267,673 $0 $24,047
Ajay Goel (Director Research) $259,063 $0 $8,560
Elizabeth Cothran (Vp Chief Regulatory Office) $251,050 $0 $47,889
Jennifer Thomas (Vp Research Operations) $248,140 $0 $39,508
Paul Grayburn Md (Medical Director) $222,600 $76,692 $0
Renee Day (Vp Cfo (Thru 7/22/19)) $221,043 $0 $49,133
Steven Newton (Trustee) $0 $1,292,126 $302,447
Alejandro Arroliga Md (Trustee) $0 $1,195,061 $144,557
Michael J Mack Md (Trustee/Chair) $0 $1,010,708 $18,295
Michael Ramsay Md (President/Ceo) $0 $611,119 $36,388
Amy Martin (Vp Cfo (Eff 10/22/19)) $0 $320,280 $38,657

Document Links

Fiscal Year Ending June
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$69,331,263
Expenses
$69,230,447
Net Income
$100,816
Net Assets
$150,062,185
Notable Sources of Revenue Percent of Total Revenue
Contributions $44,547,066
64.3%
Program Services $23,281,627
33.6%
Investment Income $155,005
0.2%
Bond Proceeds $0
Royalties $5,740,703
8.3%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$4,654,622
Net Inventory Sales $0
Other Revenue $261,484
0.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,118,986
1.6%
Professional Fundraising Fees $0
Other Salaries and Wages $29,031,763
41.9%
Assets/Debt
Total Assets $165,250,659
Total Liabilities $15,188,474
Net Assets $150,062,185
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Jaime Walkowiak (Secretary/Svp Coo) $454,073 $0 $66,721
Ajay Goel (Director Research) $304,051 $0 $36,998
Gerard Zurawski (Director Inst. Immunology Research) $302,555 $0 $14,539
Renee Day (Vp Finance/Cfo) $272,088 $0 $63,751
Alan Stevens (Dir Comm & Applied Health Rsch) $268,307 $0 $24,250
Elizabeth Cothran (Vp Chief Regulatory Officer) $241,630 $0 $45,421
Jennifer Thomas (Vp Research Operations) $240,867 $0 $42,141
Paul Grayburn Md (Medical Director) $216,600 $81,009 $15,964
Shelley Conroy (Trustee) $0 $0 $0
Kent Eastman (Trustee) $0 $0 $0
Ronald D Murff (Trustee/Chair) $0 $0 $0
Steven Newton (Trustee) $0 $1,177,219 $277,323
Erle Nye (Trustee) $0 $0 $0
Robert A Probe Md (Trustee (Thru 2/21/19)) $0 $1,280,054 $336,963
Alejandro Arroliga Md (Trustee (Eff 2/21/19)) $0 $1,080,191 $134,617
Michael Ramsay Md (President/Ceo) $0 $606,457 $33,419

Document Links

Fiscal Year Ending June
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$74,456,233
Expenses
$70,238,304
Net Income
$4,217,929
Net Assets
$126,571,299
Notable Sources of Revenue Percent of Total Revenue
Contributions $49,203,979
66.1%
Program Services $21,936,276
29.5%
Investment Income $92,621
0.1%
Bond Proceeds $0
Royalties $2,450,804
3.3%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$314,643
Net Inventory Sales $0
Other Revenue $1,087,196
1.5%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,072,725
1.5%
Professional Fundraising Fees $0
Other Salaries and Wages $27,998,513
39.9%
Assets/Debt
Total Assets $149,737,447
Total Liabilities $23,166,148
Net Assets $126,571,299
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Ajay Goel (Director Research) $451,468 $0 $36,428
Jaime Walkowiak (Secretary/Svp Coo) $433,460 $0 $70,682
Gerard Zurawski (Director Inst. Immunology Research) $292,555 $0 $14,266
Renee Day (Vp Finance/Cfo) $254,755 $0 $65,957
Alan Stevens (Dir Comm & Applied Health Rsch) $235,380 $26,987 $23,011
Shahid Shafi (Medical Director) $234,940 $5,588 $11,747
Moshe Levy Md (Medical Director) $232,931 $0 $10,530
Elizabeth Cothran (Vp Chief Regulatory Officer) $222,514 $0 $47,361
Kent Eastman (Trustee) $0 $0 $0
John Mc Whorter (Trustee) $0 $1,793,414 $431,168
Ronald D Murff (Trustee/Chair) $0 $0 $0
Erle Nye (Trustee) $0 $0 $0
Robert A Probe Md (Trustee) $0 $1,310,630 $272,222
Shelley Conroy (Trustee) $0 $0 $0
Steven Newton (Trustee) $0 $1,101,643 $272,635
Michael Ramsay Md (President/Ceo) $0 $601,804 $32,061

Document Links

Fiscal Year Ending June
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$67,527,910
Expenses
$67,109,598
Net Income
$418,312
Net Assets
$109,687,177
Notable Sources of Revenue Percent of Total Revenue
Contributions $43,094,084
63.8%
Program Services $20,496,815
30.4%
Investment Income $33,856
0.1%
Bond Proceeds $0
Royalties $3,896,999
5.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$1,583
Net Inventory Sales $0
Other Revenue $7,739
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,080,469
1.6%
Professional Fundraising Fees $0
Other Salaries and Wages $27,467,585
40.9%
Assets/Debt
Total Assets $136,825,951
Total Liabilities $27,138,774
Net Assets $109,687,177
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Jaime Walkowiak (Secretary/Svp Coo) $435,881 $0 $64,432
Ajay Goel (Director Research) $323,658 $0 $38,157
Maria Pascual (Director Clinical Research) $318,701 $0 $8,630
Gerard Zurawski (Director Inst. Immunology) $282,127 $0 $13,787
Shahid Shafi (Medical Director) $280,492 $0 $13,791
Renee Day (Vp Finance/Cfo) $255,913 $0 $62,748
Moshe Levy Md (Medical Director) $250,813 $0 $481
Elizabeth Cothran (Vp Chief Regulatory Officer) $222,886 $0 $50,138
Kent Eastman (Trustee) $0 $0 $0
John Mc Whorter (Trustee) $0 $1,634,088 $405,660
Ronald D Murff (Trustee/Chair) $0 $0 $0
Erle Nye (Trustee) $0 $0 $0
Robert A Probe Md (Trustee) $0 $1,262,746 $167,550
Shelley Conroy (Trustee) $0 $0 $0
Michael Ramsay Md (President) $0 $631,884 $19,629

Document Links

Fiscal Year Ending June
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$61,713,937
Expenses
$61,826,347
Net Income
-$112,410
Net Assets
$108,291,000
Notable Sources of Revenue Percent of Total Revenue
Contributions $39,229,580
63.6%
Program Services $19,661,135
31.9%
Investment Income $20,053
0.0%
Bond Proceeds $0
Royalties $2,763,775
4.5%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$18,587
Net Inventory Sales $0
Other Revenue $57,981
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,038,338
1.7%
Professional Fundraising Fees $0
Other Salaries and Wages $26,253,769
42.5%
Assets/Debt
Total Assets $135,691,222
Total Liabilities $27,400,222
Net Assets $108,291,000
Compensation
Key Employees and Officers Compensation Related Other
Jaime Walkowiak (Secretary/Svp Coo) $370,010 $0 $58,066
Ajay Goel (Director Research) $353,875 $0 $37,933
Maria Pascual (Director Clinical Research Services) $339,782 $0 $9,662
Gerard Zurawski (Director Inst. Immunology Research) $296,980 $0 $13,786
Renee Day (Vp Finance/Cfo) $266,720 $0 $55,701
Moshe Levy Md (Medical Director) $251,040 $0 $482
Tawanda Gumbo (Investigator) $232,503 $0 $36,196
Elizabeth Cothran (Vp Chief Regulatory Officer) $223,739 $0 $45,137
Paul Convery Md (Director) $0 $165,696 $0
Kent Eastman (Director) $0 $0 $0
John Mc Whorter (Director) $0 $1,907,354 $381,368
Ronald D Murff (Director/Chairman) $0 $0 $0
Erle Nye (Director) $0 $0 $0
Michael Ramsay Md (President) $0 $597,525 $21,266

Document Links

Fiscal Year Ending June
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$61,768,964
Expenses
$63,008,893
Net Income
-$1,239,929
Net Assets
$110,038,268
Notable Sources of Revenue Percent of Total Revenue
Contributions $40,516,275
65.6%
Program Services $18,089,192
29.3%
Investment Income $5,980
0.0%
Bond Proceeds $0
Royalties $2,692,450
4.4%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$1,833
Net Inventory Sales $0
Other Revenue $466,900
0.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,009,201
1.6%
Professional Fundraising Fees $0
Other Salaries and Wages $24,055,144
38.2%
Assets/Debt
Total Assets $138,238,739
Total Liabilities $28,200,471
Net Assets $110,038,268
Compensation
Key Employees and Officers Compensation Related Other
Jaime Walkowiak (Vp Research Ops/Bus Devel/Secretary) $315,836 $0 $50,076
Maria Pascual (Director Clinical Research Services) $309,845 $0 $8,548
Gerard Zurawski (Director Inst. Immunology Research) $293,403 $0 $13,489
Ajay Goel (Director Research Center) $292,706 $0 $33,773
Clement Boland Md (Medical Director) $252,486 $32,064 $74,985
Renee Day (Vp Finance/Cfo) $224,253 $0 $39,881
Elizabeth Cothran (Vp Chief Regulatory Officer) $167,546 $0 $26,424
Moshe Levy Md (Medical Director) $124,430 $126,030 $548
Paul Convery Md (Director) $0 $51,900 $0
John Mc Whorter (Director) $0 $1,592,088 $271,801
Erle Nye (Director) $0 $0 $0
Kent Eastman (Director) $0 $0 $0
Ronald D Murff (Chairman) $0 $0 $0
Michael Ramsay Md (President) $0 $708,851 $84,610

Document Links

Fiscal Year Ending June
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$68,465,974
Expenses
$61,860,765
Net Income
$6,605,209
Net Assets
$110,436,908
Notable Sources of Revenue Percent of Total Revenue
Contributions $64,944,746
94.9%
Program Services $4,761,464
7.0%
Investment Income $5,496
0.0%
Bond Proceeds $0
Royalties $1,020,372
1.5%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$2,741
Net Inventory Sales $0
Other Revenue -$2,263,363
Notable Expenses Percent of Total Expenses
Executive Compensation $1,038,813
1.7%
Professional Fundraising Fees $0
Other Salaries and Wages $24,066,103
38.9%
Assets/Debt
Total Assets $148,560,662
Total Liabilities $38,123,754
Net Assets $110,436,908
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Maria Pascual (Director Clinical Research) $631,978 $0 $13,784
Yong Jun Liu (Chief Scientific Officer) $586,430 $0 $84,865
Anna Palucka (Clinical Mgmt Researcher) $301,671 $0 $27,348
Gerard Zurawski (Program Director) $271,572 $0 $12,292
Shahid Shafi (Principal Investigator) $236,138 $62,000 $12,260
Jaime Walkowiak (Vp Research Ops/Bus Devel) $232,198 $0 $25,852
Ajay Goel (Program Director) $207,947 $0 $24,861
Renee Day (Vp Finance/Cfo) $196,069 $0 $30,365
Michael Ramsay Md (President) $186,505 $559,512 $73,084
Paul Convery Md (Director) $0 $1,041,418 $239,828
John Mc Whorter (Director) $0 $970,303 $230,554
Erle Nye (Director) $0 $1,456 $0
Kent Eastman (Director) $0 $0 $0
Ronald D Murff (Chairman) $0 $0 $0

Document Links

Fiscal Year Ending June
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$56,390,365
Expenses
$62,159,368
Net Income
-$5,769,003
Net Assets
$99,800,353
Notable Sources of Revenue Percent of Total Revenue
Contributions $46,975,848
83.3%
Program Services $4,339,804
7.7%
Investment Income $9,925
0.0%
Bond Proceeds $0
Royalties $2,300,107
4.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$36,832
Net Inventory Sales $0
Other Revenue $2,801,513
5.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,296,220
2.1%
Professional Fundraising Fees $0
Other Salaries and Wages $22,741,381
36.6%
Assets/Debt
Total Assets $151,818,242
Total Liabilities $52,017,889
Net Assets $99,800,353

Document Links

Fiscal Year Ending June
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$57,804,654
Expenses
$55,949,126
Net Income
$1,855,528
Net Assets
$101,072,992
Notable Sources of Revenue Percent of Total Revenue
Contributions $49,538,025
85.7%
Program Services $3,294,638
5.7%
Investment Income $11,439
0.0%
Bond Proceeds $0
Royalties $2,738,811
4.7%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $10,909
0.0%
Net Inventory Sales $0
Other Revenue $2,210,832
3.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,531,231
2.7%
Professional Fundraising Fees $0
Other Salaries and Wages $20,539,113
36.7%
Assets/Debt
Total Assets $135,886,713
Total Liabilities $34,813,721
Net Assets $101,072,992

Document Links

Fiscal Year Ending June
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$51,740,018
Expenses
$53,563,247
Net Income
-$1,823,229
Net Assets
$87,758,702
Notable Sources of Revenue Percent of Total Revenue
Contributions $51,515,842
99.6%
Program Services $4,099,548
7.9%
Investment Income $7,101
0.0%
Bond Proceeds $0
Royalties $449,714
0.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$249,512
Net Inventory Sales $0
Other Revenue -$4,082,675
Notable Expenses Percent of Total Expenses
Executive Compensation $1,001,233
1.9%
Professional Fundraising Fees $0
Other Salaries and Wages $18,685,060
34.9%
Assets/Debt
Total Assets $118,062,719
Total Liabilities $30,304,017
Net Assets $87,758,702

Document Links

Fiscal Year Ending June
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2002

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2001

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »